Study on the effect of combination therapy of alpha-1 blocker and transdermal oxybutynin hydrochloride in patients with overactive bladder due to benign prostatic hyperplasia
Not Applicable
- Conditions
- Patients with overactive bladder due to benign prostatic hyperplasia
- Registration Number
- JPRN-UMIN000021414
- Lead Sponsor
- Department of Renal and Urologic Surgery, Asahikawa Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
Qmax on uroflowmetry 5ml/sec or less, postvoid residual urine 100ml or more, patients who underwent radiation to the prostate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in total score of overactive bladder symptoms score(OABSS) 4weeks after the intervention
- Secondary Outcome Measures
Name Time Method Change in each item of OABSS 4weeks after the intervention Change in International Prostate Symptoms Score 4weeks after the intervention